BRIEF published on 10/28/2024 at 09:34, 5 months 10 days ago Le groupe Fielmann obtient le statut C+ Prime dans la notation ESG Investissement Durabilité Soins De Santé Groupe Fielmann Notation ESG
PRESS RELEASE published on 10/28/2024 at 09:29, 5 months 10 days ago Fielmann Group awarded C+ Prime Status ESG rating in the Healthcare category Fielmann Group receives C+ Prime Status ESG rating in Healthcare category from ISS ESG, enabling broader investment opportunities. Achieved decile rank of 2 in sector ESG Rating Sustainable Investments Fielmann Group Healthcare Category Decile Rank
BRIEF published on 08/29/2024 at 07:34, 7 months 9 days ago Le chiffre d'affaires du groupe Fielmann progresse de +11% au 1er semestre 2024, l'EBITDA de +14% et l'EBT de +17% par rapport à l'année précédente EBITDA Expansion Internationale Croissance Des Ventes Groupe Fielmann Premier Semestre 2024
BRIEF published on 08/29/2024 at 07:34, 7 months 9 days ago Fielmann Group sales grow by +11% in HY1/2024, EBITDA by +14% and EBT by +17% compared to previous year EBITDA Sales Growth International Expansion Fielmann Group HY1 2024
PRESS RELEASE published on 08/29/2024 at 07:29, 7 months 9 days ago Fielmann Group sales grow by +11% in HY1/2024, EBITDA by +14% and EBT by +17% compared to previous year Fielmann Group AG reports +11% sales growth in HY1/2024, with EBITDA and EBT up by +14% and +17% respectively compared to previous year. Company continues international expansion EBITDA Sales Growth International Expansion Fielmann Group AG HY1/2024
BRIEF published on 07/11/2024 at 07:34, 8 months 27 days ago Le groupe Fielmann augmente ses ventes du premier semestre 2024 de 12 % et améliore sa rentabilité Rentabilité Numérisation La Croissance Des Ventes Fielmann S1/2024
BRIEF published on 07/11/2024 at 07:34, 8 months 27 days ago Fielmann Group Grows HY1/2024 Sales by 12%, Improves Profitability Profitability Sales Growth Digitalisation Fielmann HY1/2024
PRESS RELEASE published on 07/11/2024 at 07:29, 8 months 27 days ago Fielmann Group grows HY1/2024 sales +12% over 2023, improves profitability Fielmann Group reports 12% sales growth in HY1/2024, with improved profitability and outlook for Vision 2025. Digitalization and international expansion drive growth Profitability Digitalization Fielmann Group HY1/2024 Sales Vision 2025
BRIEF published on 07/01/2024 at 14:32, 9 months 6 days ago Fielmann Group Closes Acquisition of Shopko Optical and Increases FY2024 Outlook Acquisition Fielmann Group Shopko Optical FY2024 Outlook Optical Retail
BRIEF published on 07/01/2024 at 14:32, 9 months 6 days ago Le groupe Fielmann finalise l'acquisition de Shopko Optical et augmente ses perspectives pour l'exercice 2024 Acquisition Groupe Fielmann Optique Shopko Perspectives Pour L'exercice 2024 Commerce De Détail D'optique
Published on 04/07/2025 at 14:30, 27 minutes ago Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 27 minutes ago Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 57 minutes ago NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 57 minutes ago Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 14:00, 57 minutes ago Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
Published on 04/07/2025 at 14:24, 32 minutes ago OTRS AG: Voluntary Public Tender Offer of Optimus BidCo AG
Published on 04/07/2025 at 13:00, 1 hour 57 minutes ago CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 2 hours ago PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 59 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 04/07/2025 at 07:01, 7 hours 56 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 7 hours 56 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 19 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 19 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 20 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
